Literature DB >> 26020104

Assessment of Modification of Diet in Renal Disease Equation to Predict Reference Serum Creatinine Value in Severe Trauma Patients: Lessons From an Observational Study of 775 Cases.

Marine Saour1, Kada Klouche, Pauline Deras, Asmaa Damou, Xavier Capdevila, Jonathan Charbit.   

Abstract

OBJECTIVE: We assessed the Modification of Diet in Renal Disease (MDRD) performance to predict serum creatinine (SCr) in severe trauma population and determined the best theoretical glomerular filtration rate (GFR) to use in this estimation.
BACKGROUND: Baseline SCr may be misestimated in severe trauma patients because of their specific demographic characteristics including renal hyperfiltration. However, the back-calculated MDRD equation is supposed to estimate SCr using a predetermined GFR of 75 mL/min/1.73 m.
METHODS: All severe trauma patients with a normal SCr were retrospectively included between January 2005 and January 2011. For each patient, the lowest SCr (oSCr) observed during the first week was used to estimate the GFR. The median GFR in period 1 (2005-2006) was determined. The back-calculated MDRD performance was assessed in period 2 (2007-2011) to predict oSCr by agreement, precision, and accuracy using a GFR of 75 mL/min/1.73 m (eSCr75-MDRD) or the median GFR observed in period 1 (eSCrTRAUMA-MDRD).
RESULTS: A total of 775 patients were studied: mean age, 37.7 ± 17 years; mean Injury Severity Score, 19 ± 11; 75% of male. In period 1 (n = 243), median GFR was 121 mL/min/1.73 m. In period 2 (n = 532), eSCrTRAUMA-MDRD demonstrated better agreement in predicting oSCr than eSCr75-MDRD (mean bias 2 vs 35 μmol/L; P < 0.001). Both precision (14 vs 39 μmol/L, respectively) and accuracy were significantly improved with eSCrTRAUMA-MDRD. Proportion of estimated SCr values that deviated less than 15%, 30%, or 50% was also higher with eSCrTRAUMA-MDRD (P < 0.001).
CONCLUSIONS: The eSCr75-MDRD equation systematically overestimates oSCr of severe trauma patients. The eSCrTRAUMA-MDRD equation determined was statistically superior allowing more accurate qualification of acute kidney injury.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26020104     DOI: 10.1097/SLA.0000000000001163

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  6 in total

1.  Addressing Racial Differences in Baseline Kidney Function Estimates for Trauma Care: In reply to Lee and Colleagues.

Authors:  Gabrielle E Hatton; Charles E Wade; Lillian S Kao
Journal:  J Am Coll Surg       Date:  2020-07-24       Impact factor: 6.113

2.  Elevated urea-to-creatinine ratio provides a biochemical signature of muscle catabolism and persistent critical illness after major trauma.

Authors:  Ryan W Haines; Parjam Zolfaghari; Yize Wan; Rupert M Pearse; Zudin Puthucheary; John R Prowle
Journal:  Intensive Care Med       Date:  2019-09-17       Impact factor: 17.440

3.  Choice of Reference Creatinine for Post-Traumatic Acute Kidney Injury Diagnosis.

Authors:  Gabrielle E Hatton; Reginald E Du; Claudia Pedroza; Shuyan Wei; John A Harvin; Kevin W Finkel; Charles E Wade; Lillian S Kao
Journal:  J Am Coll Surg       Date:  2019-09-20       Impact factor: 6.113

4.  Prevalence and risk factors for acute kidney injury among trauma patients: a multicenter cohort study.

Authors:  Anatole Harrois; Benjamin Soyer; Tobias Gauss; Sophie Hamada; Mathieu Raux; Jacques Duranteau
Journal:  Crit Care       Date:  2018-12-18       Impact factor: 9.097

Review 5.  Prevalence and Risk Factors of Augmented Renal Clearance: A Systematic Review and Meta-Analysis.

Authors:  Fatma Hefny; Anna Stuart; Janice Y Kung; Sherif Hanafy Mahmoud
Journal:  Pharmaceutics       Date:  2022-02-19       Impact factor: 6.321

6.  Acute Kidney Injury in Trauma Patients Admitted to Critical Care: Development and Validation of a Diagnostic Prediction Model.

Authors:  Ryan W Haines; Shih-Pin Lin; Russell Hewson; Christopher J Kirwan; Hew D Torrance; Michael J O'Dwyer; Anita West; Karim Brohi; Rupert M Pearse; Parjam Zolfaghari; John R Prowle
Journal:  Sci Rep       Date:  2018-02-26       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.